Alnylam Pharmaceuticals
Massachusetts, United States
1,001-5,000 Employees
Healthcare
•Tech
Director, Patient Advocacy and Engagement
Alabama, --
Full time
Description
Alnylam Pharmaceuticals (NASDAQ: ALNY) is a biopharmaceutical company founded in 2002, focused on developing RNA interference (RNAi) therapeutics for a wide range of diseases. The company's innovative approach to gene silencing has the potential to revolutionize the treatment of genetic and rare diseases, providing new hope for patients worldwide. Alnylam is committed to advancing cutting-edge science and delivering transformative therapies to improve the lives of those in need.
Financials
Type
public
Annual Revenue
--
Market Cap
$37.6B+
Subscribe to Refer Me premium to get referred to this role at Alnylam Pharmaceuticals!
